Literature DB >> 27055456

Determination of the unbound fraction of R- and S-methadone in human brain.

Karen M D Holm1, Kristian Linnet2.   

Abstract

According to the free drug hypothesis, only the unbound fraction (f u ) of a given drug is biologically available in terms of its pharmacologic activity. Methadone shows large interpersonal variation in toxicity. The goal of the work presented here was to examine whether isolating the unbound fraction of the active R-methadone enantiomer from brain matter could be of value as a forensic tool. A method applying equilibrium dialysis to postmortem brain samples was validated and showed good reproducibility for the previously published f u values for eight common drugs (alprazolam, citalopram, codeine, methadone, morphine, diazepam, oxycodone, tramadol), as well as methadone enantiomers. This method was then applied to approximately 50 authentic case samples with R-methadone and S-methadone concentrations ranging from 0.03 to 13 and 0.6 to 6.8 mg/kg, respectively; median f u values (R-and S-methadone) were 3.9 % (range 3.0-5.3 %) and 3.7 % (range 2.9-4.9 %). No overall correlation between the active R-methadone concentration and f u were found. Small but statistically significant differences in median f u for the R-methadone enantiomer were identified between case-categories (i.e., poisoning with multiple drugs, methadone poisoning, and deaths unrelated to methadone), but these are thought to be too low to be of any forensic value.

Entities:  

Keywords:  Brain concentration; Equilibrium dialysis; Forensic toxicology; Methadone; R/S-enantiomers; Unbound fraction

Mesh:

Substances:

Year:  2016        PMID: 27055456     DOI: 10.1007/s00414-016-1365-9

Source DB:  PubMed          Journal:  Int J Legal Med        ISSN: 0937-9827            Impact factor:   2.686


  40 in total

1.  Chiral separation and quantification of R/S-amphetamine, R/S-methamphetamine, R/S-MDA, R/S-MDMA, and R/S-MDEA in whole blood by GC-EI-MS.

Authors:  Louise Bang Rasmussen; Kristine Høje Olsen; Sys Stybe Johansen
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2006-06-21       Impact factor: 3.205

2.  Receptor occupancy and brain free fraction.

Authors:  Jeanette Watson; Sara Wright; Adam Lucas; Kirsten L Clarke; Jean Viggers; Sharon Cheetham; Phil Jeffrey; Rod Porter; Kevin D Read
Journal:  Drug Metab Dispos       Date:  2009-01-21       Impact factor: 3.922

3.  Brain and plasma levels of methadone and their relationships to analgesic activity of methadone in rats.

Authors:  S J Liu; D L Roerig; R I Wang
Journal:  Drug Metab Dispos       Date:  1983 Jul-Aug       Impact factor: 3.922

4.  Improving the in vitro prediction of in vivo central nervous system penetration: integrating permeability, P-glycoprotein efflux, and free fractions in blood and brain.

Authors:  Scott G Summerfield; Alexander J Stevens; Leanne Cutler; Maria del Carmen Osuna; Beverley Hammond; Sac-Pham Tang; Ann Hersey; David J Spalding; Phil Jeffrey
Journal:  J Pharmacol Exp Ther       Date:  2005-12-05       Impact factor: 4.030

5.  Free and bound enantiomers of methadone and its metabolite, EDDP in methadone maintenance treatment: relationship to dosage?

Authors:  D C Lehotay; S George; M L Etter; K Graybiel; J C Eichhorst; B Fern; W Wildenboer; P Selby; B Kapur
Journal:  Clin Biochem       Date:  2005-11-10       Impact factor: 3.281

6.  Distribution of enantiomers of methadone and its main metabolite EDDP in human tissues and blood of postmortem cases.

Authors:  Karen Marie Dollerup Holm; Kristian Linnet
Journal:  J Forensic Sci       Date:  2014-11-24       Impact factor: 1.832

7.  Methadone binding to orosomucoid (alpha 1-acid glycoprotein): determinant of free fraction in plasma.

Authors:  M K Romach; K M Piafsky; J G Abel; V Khouw; E M Sellers
Journal:  Clin Pharmacol Ther       Date:  1981-02       Impact factor: 6.875

8.  Enantioselective determination of 3-n-butylphthalide (NBP) in human plasma by liquid chromatography on a teicoplanin-based chiral column coupled with tandem mass spectrometry.

Authors:  Xingxing Diao; Zhiyu Ma; Peng Lei; Dafang Zhong; Yifan Zhang; Xiaoyan Chen
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2013-09-17       Impact factor: 3.205

9.  The mu1, mu2, delta, kappa opioid receptor binding profiles of methadone stereoisomers and morphine.

Authors:  K Kristensen; C B Christensen; L L Christrup
Journal:  Life Sci       Date:  1995       Impact factor: 5.037

10.  Toward an improved prediction of human in vivo brain penetration.

Authors:  S G Summerfield; A J Lucas; R A Porter; P Jeffrey; R N Gunn; K R Read; A J Stevens; A C Metcalf; M C Osuna; P J Kilford; J Passchier; A D Ruffo
Journal:  Xenobiotica       Date:  2008-12       Impact factor: 1.908

View more
  2 in total

1.  Determination of the unbound fraction of R- and S-methadone in human brain.

Authors:  Xiulu Ruan; Ken F Mancuso; Alan David Kaye
Journal:  Int J Legal Med       Date:  2016-07-25       Impact factor: 2.686

2.  Efficacy of D,L-methadone in the treatment of glioblastoma in vitro.

Authors:  Konstantin Brawanski; Gero Brockhoff; Peter Hau; Arabel Vollmann-Zwerenz; Christian Freyschlag; Annette Lohmeier; Markus J Riemenschneider; Claudius Thomé; Alexander Brawanski; Martin A Proescholdt
Journal:  CNS Oncol       Date:  2018-06-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.